<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font17 { font-size : 17; } .font18 { font-size : 18; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">HPV </span>
   <span class="font18">particles </span>
   <span class="font18">antibodies </span>
   <span class="font17">mice </span>
   <span class="font17">AAVLP(HPV/L) </span>
   <span class="font16">capsid </span>
   <span class="font16">AAV </span>
   <span class="font15">protein </span>
   <span class="font14">immunized </span>
   <span class="font14">sera </span>
   <span class="font14">titers </span>
   <span class="font13">cross-neutralizing </span>
   <span class="font13">human </span>
   <span class="font13">peptides </span>
   <span class="font13">AAVLP </span>
   <span class="font13">HPV, </span>
   <span class="font13">using </span>
   <span class="font13">infection </span>
   <span class="font13">AAVLPs </span>
   <span class="font13">papillomavirus </span>
   <span class="font12">neutralizing </span>
   <span class="font12">vaccinated </span>
   <span class="font12">weeks </span>
   <span class="font12">Balb/c </span>
   <span class="font12">L-specific </span>
   <span class="font12">animals </span>
   <span class="font12">antibody </span>
   <span class="font12">peptide </span>
   <span class="font12">position </span>
   <span class="font12">figure </span>
   <span class="font12">ISA </span>
   <span class="font12">montanide </span>
   <span class="font12">neutralization </span>
   <span class="font12">types </span>
   <span class="font12">PsV </span>
   <span class="font12">Virol </span>
   <span class="font12">different </span>
   <span class="font12">immune </span>
   <span class="font12">low </span>
   <span class="font12">rabbit </span>
   <span class="font12">vaccination </span>
   <span class="font12">virus </span>
   <span class="font11">containing </span>
   <span class="font11">dose </span>
   <span class="font11">generated </span>
   <span class="font11">group </span>
   <span class="font11">high </span>
   <span class="font11">induced </span>
   <span class="font11">plasmid </span>
   <span class="font11">shown </span>
   <span class="font11">times </span>
   <span class="font11">vaccine </span>
   <span class="font11">vaccines </span>
   <span class="font11">CBL/ </span>
   <span class="font11">activity </span>
   <span class="font11">adeno-associated </span>
   <span class="font11">adjuvant </span>
   <span class="font11">capsids </span>
   <span class="font11">cells </span>
   <span class="font11">epitope </span>
   <span class="font11">inserted </span>
   <span class="font11">insertion </span>
   <span class="font11">measured </span>
   <span class="font11">purified </span>
   <span class="font11">rabbits </span>
   <span class="font11">used </span>
   <span class="font11">Data </span>
   <span class="font11">ELISA </span>
   <span class="font11">analyzed </span>
   <span class="font11">broadly </span>
   <span class="font11">detected </span>
   <span class="font11">diluted </span>
   <span class="font11">dilutions </span>
   <span class="font11">epitopes </span>
   <span class="font11">immunization </span>
   <span class="font11">luciferase </span>
   <span class="font11">./journal.pone..g </span>
   <span class="font11">Animals </span>
   <span class="font11">Figure </span>
   <span class="font11">Gambhira </span>
   <span class="font11">IgG </span>
   <span class="font11">Particles </span>
   <span class="font11">Virology </span>
   <span class="font11">antibodies. </span>
   <span class="font11">assay. </span>
   <span class="font11">challenge </span>
   <span class="font11">days </span>
   <span class="font11">expression </span>
   <span class="font11">gene </span>
   <span class="font11">high-risk </span>
   <span class="font11">immunogenicity </span>
   <span class="font11">obtained </span>
   <span class="font11">positions </span>
   <span class="font11">protective </span>
   <span class="font11">pseudovirion </span>
   <span class="font11">pseudovirions </span>
   <span class="font11">responses </span>
   <span class="font11">similar </span>
   <span class="font11">tested </span>
   <span class="font11">transfer </span>
   <span class="font11">Cross-neutralizing </span>
   <span class="font11">binding </span>
   <span class="font11">buffer </span>
   <span class="font11">cell </span>
   <span class="font11">determined </span>
   <span class="font11">equivalent </span>
   <span class="font11">higher </span>
   <span class="font11">individual </span>
   <span class="font11">mice. </span>
   <span class="font11">plates </span>
   <span class="font11">potential </span>
   <span class="font11">sites </span>
   <span class="font11">study </span>
   <span class="font11">type </span>
   <span class="font11">vectors </span>
   <span class="font11">viral </span>
   <span class="font11">µg) </span>
   <span class="font10">AAVLP(HPV/L). </span>
   <span class="font10">DR, </span>
   <span class="font10">Detection </span>
   <span class="font10">Gene </span>
   <span class="font10">Germany). </span>
   <span class="font10">HPV. </span>
   <span class="font10">Jagu </span>
   <span class="font10">Karanam </span>
   <span class="font10">Lowy </span>
   <span class="font10">Natl </span>
   <span class="font10">Roden </span>
   <span class="font10">Sci </span>
   <span class="font10">Sera </span>
   <span class="font10">amino </span>
   <span class="font10">assembly </span>
   <span class="font10">cervical </span>
   <span class="font10">described </span>
   <span class="font10">developed </span>
   <span class="font10">followed </span>
   <span class="font10">highly </span>
   <span class="font10">insertions </span>
   <span class="font10">minor </span>
   <span class="font10">monoclonal </span>
   <span class="font10">presence </span>
   <span class="font10">prior </span>
   <span class="font10">recombinant </span>
   <span class="font10">residues </span>
   <span class="font10">sequence </span>
   <span class="font10">surface </span>
   <span class="font10">titer </span>
   <span class="font10">(AAV) </span>
   <span class="font10">(LDM </span>
   <span class="font10">(MPL) </span>
   <span class="font10">(position </span>
   <span class="font10">Acad </span>
   <span class="font10">Adeno-associated </span>
   <span class="font10">B-cell </span>
   <span class="font10">Briefly, </span>
   <span class="font10">Buck </span>
   <span class="font10">CB, </span>
   <span class="font10">Cervarix™ </span>
   <span class="font10">GST-L </span>
   <span class="font10">Gardasil™ </span>
   <span class="font10">However, </span>
   <span class="font10">JN, </span>
   <span class="font10">Mean </span>
   <span class="font10">Med </span>
   <span class="font10">Neutralizing </span>
   <span class="font10">Proc </span>
   <span class="font10">Production </span>
   <span class="font10">Roberts </span>
   <span class="font10">Ther </span>
   <span class="font10">TrXLM </span>
   <span class="font10">VLPs </span>
   <span class="font10">VP, </span>
   <span class="font10">Vaccine </span>
   <span class="font10">Western </span>
   <span class="font10">adjuvant. </span>
   <span class="font10">analysis </span>
   <span class="font10">animal </span>
   <span class="font10">antigen </span>
   <span class="font10">bars. </span>
   <span class="font10">cancer </span>
   <span class="font10">candidate </span>
   <span class="font10">challenge, </span>
   <span class="font10">data </span>
   <span class="font10">doses </span>
   <span class="font10">expressed </span>
   <span class="font10">female </span>
   <span class="font10">genital </span>
   <span class="font10">horizontal </span>
   <span class="font10">i.m. </span>
   <span class="font10">immunization. </span>
   <span class="font10">immunogenic </span>
   <span class="font10">increased </span>
   <span class="font10">incubated </span>
   <span class="font10">incubation </span>
   <span class="font10">intramuscularly </span>
   <span class="font10">lower </span>
   <span class="font10">major </span>
   <span class="font10">membrane </span>
   <span class="font10">pCIVPmut-I </span>
   <span class="font10">papillomaviruses </span>
   <span class="font10">particles. </span>
   <span class="font10">pellet </span>
   <span class="font10">performed </span>
   <span class="font10">prevent </span>
   <span class="font10">previously </span>
   <span class="font10">produced </span>
   <span class="font10">production </span>
   <span class="font10">prophylactic </span>
   <span class="font10">proteins </span>
   <span class="font10">reciprocal </span>
   <span class="font10">resuspended </span>
   <span class="font10">serial </span>
   <span class="font10">shown. </span>
   <span class="font10">specific </span>
   <span class="font10">stable </span>
   <span class="font10">stored </span>
   <span class="font10">sucrose </span>
   <span class="font10">vaginal </span>
  </p>
 </body>
</html>
